Business, energy, technology, markets and global industry news from Business News Today

respiratory immunology

PharmaDeviceNews respiratory immunology
Representative image: OM Pharma’s Broncho-Vaxom OM-85 real-world evidence study highlights growing clinical interest in respiratory tract infection prevention, non-antibiotic care strategies, and data-driven respiratory health research.
Pharma & Biotech

Could OM Pharma’s Broncho-Vaxom study change how clinicians assess recurrent RTI prevention?

Find out how OM Pharma’s Broncho-Vaxom data could reshape RTI prevention, real-world evidence and non-antibiotic care strategies.

Read More
Pharma & Biotech

Harbour BioMed HBM9378 Phase I data: does long-acting TSLP inhibition change asthma treatment economics?

Harbour BioMed’s HBM9378 Phase I data shows long half-life and safety. Find out what this means for asthma, COPD, and TSLP competition.

Read More